| Bioactivity | PROTAC RIPK degrader-2 is a nonpeptidic PROTAC based on von Hippel-Lindau ligand which potently targets serine-threonine kinase RIPK2 and has highly selective for RIPK2 degradation[1]. | ||||||||||||
| Name | PROTAC RIPK degrader-2 | ||||||||||||
| CAS | 1801547-16-9 | ||||||||||||
| Formula | C52H65N7O11S3 | ||||||||||||
| Molar Mass | 1060.31 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Bondeson DP, et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat Chem Biol. 2015 Aug;11(8):611-7. |
PROTAC RIPK degrader-2
CAS: 1801547-16-9 F: C52H65N7O11S3 W: 1060.31
PROTAC RIPK degrader-2 is a nonpeptidic PROTAC based on von Hippel-Lindau ligand which potently targets serine-threonine
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.